Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer

Full metadata record
DC Field Value Language
dc.contributor.authorJung, Yoon Yang-
dc.contributor.authorLee, Yu Kyung-
dc.contributor.authorKoo, Ja Seung-
dc.date.accessioned2022-07-15T18:24:36Z-
dc.date.available2022-07-15T18:24:36Z-
dc.date.created2021-05-14-
dc.date.issued2016-02-
dc.identifier.issn1472-8222-
dc.identifier.urihttps://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/155104-
dc.description.abstractIntroduction: Beclin 1 plays a crucial role in autophagy via the Beclin 1 interactome, and is involved in various biological processes such as protein sorting, chemokinesis, and cell death. Via these biologic functions, Beclin 1 contributes to both tumor suppression and tumor progression.Areas covered: Beclin 1 plays a key biologic function on cell homeostasis and affects tumorigenesis. In this review, detailing up-to-date knowledge on the tumorigenic role of Beclin 1, its implication in breast cancer, and its utility as a breast cancer-specific drug target is discussed.Expert opinion: Because Beclin 1 is expressed in breast cancer cells, Beclin 1 could be a unique, effective drug target for the prevention and treatment of breast cancer. However, the expression of Beclin 1 varies according to cancer molecular subtypes, and Beclin 1 is involved in both breast cancer suppression and tumor progression; therefore, the decision of using a Beclin 1 inducer or inhibitor should be made based on breast cancer stage and subtype.-
dc.language영어-
dc.language.isoen-
dc.publisherTAYLOR & FRANCIS LTD-
dc.titleThe potential of Beclin 1 as a therapeutic target for the treatment of breast cancer-
dc.typeArticle-
dc.contributor.affiliatedAuthorJung, Yoon Yang-
dc.identifier.doi10.1517/14728222.2016.1085971-
dc.identifier.scopusid2-s2.0-84957936470-
dc.identifier.wosid000370868700003-
dc.identifier.bibliographicCitationEXPERT OPINION ON THERAPEUTIC TARGETS, v.20, no.2, pp.167 - 178-
dc.relation.isPartOfEXPERT OPINION ON THERAPEUTIC TARGETS-
dc.citation.titleEXPERT OPINION ON THERAPEUTIC TARGETS-
dc.citation.volume20-
dc.citation.number2-
dc.citation.startPage167-
dc.citation.endPage178-
dc.type.rimsART-
dc.type.docType정기 학술지(Review)-
dc.description.journalClass1-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.subject.keywordPlusCASPASE-MEDIATED CLEAVAGE-
dc.subject.keywordPlusREGULATES AUTOPHAGY-
dc.subject.keywordPlusLOBULAR CARCINOMA-
dc.subject.keywordPlusMOLECULAR SUBTYPE-
dc.subject.keywordPlusPOOR-PROGNOSIS-
dc.subject.keywordPlusCELL-
dc.subject.keywordPlusEXPRESSION-
dc.subject.keywordPlusAPOPTOSIS-
dc.subject.keywordPlusPROTEINS-
dc.subject.keywordPlusGENE-
dc.subject.keywordAuthorAutophagy-
dc.subject.keywordAuthorBeclin 1-
dc.subject.keywordAuthorBreast cancer-
dc.subject.keywordAuthorTargeted drug therapy-
dc.identifier.urlhttps://www.tandfonline.com/doi/full/10.1517/14728222.2016.1085971-
Files in This Item
Go to Link
Appears in
Collections
서울 의과대학 > 서울 교육협력지원교실 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher JUNG, YOON YANG photo

JUNG, YOON YANG
COLLEGE OF MEDICINE (DEPARTMENT OF MEDICAL COOPERATION)
Read more

Altmetrics

Total Views & Downloads

BROWSE